143 related articles for article (PubMed ID: 36082561)
1. [Clinical and genetic analysis of seven Chinese pedigrees affected with multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis].
Fang X; Wang H; Dong F; Lian B; Li F; Jin H; Yu Y; Zhang N; Qi X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Sep; 39(9):938-943. PubMed ID: 36082561
[TBL] [Abstract][Full Text] [Related]
2. Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors.
Tang HX; Yang H; Li F; Cao ZL; Huang YT; Qi XP
Neoplasma; 2021 Sep; 68(5):1098-1106. PubMed ID: 34156257
[TBL] [Abstract][Full Text] [Related]
3. MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.
Scapineli JO; Ceolin L; Puñales MK; Dora JM; Maia AL
Fam Cancer; 2016 Oct; 15(4):625-33. PubMed ID: 26920351
[TBL] [Abstract][Full Text] [Related]
4. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
[TBL] [Abstract][Full Text] [Related]
5. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
[TBL] [Abstract][Full Text] [Related]
6. [The clinical patterns and RET proto-oncogene identification of pheochromocytoma in 13 multiple endocrine neoplasia type 2A pedigrees].
Qi XP; Chen ZG; Jin HY; Li F; Cheng J; Ying RB; Zhao JQ; Guo DG; Luo SY; Chen GP; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2200-4. PubMed ID: 24169328
[TBL] [Abstract][Full Text] [Related]
7. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
Qi XP; Zhao JQ; Fang XD; Lian BJ; Li F; Wang HH; Cao ZL; Zheng WH; Cao J; Chen Y
BMC Cancer; 2021 Apr; 21(1):369. PubMed ID: 33827484
[TBL] [Abstract][Full Text] [Related]
9. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.
Thosani S; Ayala-Ramirez M; Palmer L; Hu MI; Rich T; Gagel RF; Cote G; Waguespack SG; Habra MA; Jimenez C
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1813-9. PubMed ID: 24030942
[TBL] [Abstract][Full Text] [Related]
10. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
[TBL] [Abstract][Full Text] [Related]
11. Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome.
Lendvai N; Tóth M; Valkusz Z; Bekő G; Szücs N; Csajbók E; Igaz P; Kriszt B; Kovács B; Rácz K; Patócs A
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):85-9. PubMed ID: 22584711
[TBL] [Abstract][Full Text] [Related]
12. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
[TBL] [Abstract][Full Text] [Related]
13. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
14. Frequent association between MEN 2A and cutaneous lichen amyloidosis.
Verga U; Fugazzola L; Cambiaghi S; Pritelli C; Alessi E; Cortelazzi D; Gangi E; Beck-Peccoz P
Clin Endocrinol (Oxf); 2003 Aug; 59(2):156-61. PubMed ID: 12864791
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report.
Li Y; Tan YQ; Tang ZX; Liao QH; Guo ZQ; Lai KB; Wang R; Chen YH
Medicine (Baltimore); 2021 Jun; 100(22):e26230. PubMed ID: 34087905
[TBL] [Abstract][Full Text] [Related]
16. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
17. The RET C611Y mutation causes MEN 2A and associated cutaneous.
Qi XP; Peng JZ; Yang XW; Zao ZL; Yu XH; Fang XD; Zhang DH; Zhao JQ
Endocr Connect; 2018 Sep; 7(9):998-1005. PubMed ID: 30300539
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
19. Bilateral Pheochromocytomas in MEN2A Syndrome: A Two-Institution Experience.
Lang BH; Yu HW; Lo CY; Lee KE; Garcia-Barcelo MM; Woo YC; Lee PC; Wong KP; Tam PK; Lam KS
World J Surg; 2015 Oct; 39(10):2484-91. PubMed ID: 26071011
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]